Clinical Trials Browser

Ovarian Neoplasms × Fenretinide × Gynecologic × Clear all

NCT01535157 2020-08-27

Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Phase 1/2 Terminated

Ovarian Neoplasms

NCT00098800 2010-03-24

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Phase NA Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms